Bristol Myers Squibb (BMY)

SG&A Expense Growth

12.93%

Quarterly · Period ending:

BMY logo

BMY SG&A Expense Growth

Latest reported12.93%
BMY Quarterly SG&A Growth (QoQ) (0.00% → 12.93%)
High-resolution chart · PNG

BMY sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
7.9193%
-2.8658%
-2.2845%
-29.2492%
43.7781%
-29.0803%
49.0491%
-29.4183%
8.3636%
-10.6659%
16.3098%
-5.2506%
3.5207%
-9.7044%
19.6131%
-7.1252%
7.0292%
-6.5096%
19.8366%
-10.3862%
6.5248%
-6.0626%
21.8344%
-10.7246%
14.8087%
-9.0772%
29.1016%
-13.5865%
18.5%
-52.0843%
63.558%
-7.6032%
11.7314%
-40.5769%
41.3043%
0.6152%
10.4985%
-16.7296%
26.1905%
-4.9057%
2.8727%
-14.4754%
26.9815%
0.3384%
1.6337%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.